Cambridge Nutritional Sciences plc provided revenue guidance for the fiscal year 2024. The company is pleased with progress over the first half of the fiscal year as the Company builds a solid foundation from which it can continue to grow. Second half is expected to remain strong, although in the absence of any further backlog to fulfill, is expected to be slightly lower than first half of fiscal year 2024 with the full year's revenue expected to be in line with market expectations.
Cambridge Nutritional Sciences plc
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 GBX | 0.00% | +18.46% | +60.42% |
Apr. 22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
Apr. 22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+60.42% | 11.41M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- ODX Stock
- News Cambridge Nutritional Sciences plc
- Cambridge Nutritional Sciences plc Provides Revenue Guidance for the Fiscal Year 2024